other

Ventfort

FDA: not-FDA-approved

Ventfort is a vascular bioregulator peptide that supports the function of vascular endothelium. It improves microcirculation, blood vessel elasticity, and helps reduce age-related vascular stiffness. Peptide bioregulator targeting vascular endothelium. Improves microcirculation and elasticity of blood vessels. Helps reduce age-related vascular stiffness. Similar in function to Vesugen -- both target cardiovascular health through vascular tissue repair. - Vascular protection and endothelial support - Microcirculation improvement - Blood vessel elasticity enhancement - Age-related cardiovascular support - Vascular stiffness reduction - Standard: 10-20 mg per cycle, SubQ or oral - Cycle: 10-20 days, repeated 2-4x/year - Route: Oral, SubQ - Similar function

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight
Half-life
CAS number
Route
02

Sourcing

Current prices

Updated today

Size unspecified

Only vendor stocking this size on the VialBase roster.

Stocks this compound Third-party tested Public COAs Positive rep

Save 15% with code VIALBASE at checkout

VialBase may earn a commission on purchases through partner links — never at additional cost to you. Full disclosure.

What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • CMP
  • CBC
  • Lipid Panel
DURING CYCLE
  • Lipid Panel
POST-CYCLE
  • CMP
  • Lipid Panel
Safety & Regulatory Status
FDA STATUS not-FDA-approved

Regulatory status for Ventfort may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.